CLB vs GRNT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLB exhibits a concerning divergence between its current market price ($17.45) and its deterministic value markers, with a Piotroski F-Score of 4/9 indicating only stable health. The stock is trading at a significant premium to both its Graham Number ($9.04) and Intrinsic Value ($4.41), while experiencing a sharp YoY earnings decline of 31.60%. Despite a strong 1-year price rally, the underlying fundamentals—specifically the negative earnings growth and bearish technical trend—suggest the current valuation is unsustainable.
GRNT presents a precarious financial profile, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of positive earnings momentum. The stock is trading at a significant premium to its Graham Number ($4.32) and Intrinsic Value ($1.26), while experiencing a catastrophic YoY EPS collapse of -94.1%. Most critically, the dividend is fundamentally unsustainable with a payout ratio of 244.44%, signaling an imminent cut. With a 0/100 technical trend and four consecutive quarterly earnings misses, the current valuation is unsupported by fundamentals.
Compare Another Pair
Related Comparisons
CLB vs GRNT: Head-to-Head Comparison
This page compares Core Laboratories Inc. (CLB) and Granite Ridge Resources, Inc. (GRNT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.